Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy (Q33492180)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy |
scientific article |
Statements
1 reference
Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy (English)
1 reference
I Tepler
1 reference
S A Cannistra
1 reference
E Frei
1 reference
R Gonin
1 reference
K C Anderson
1 reference
G Demetri
1 reference
J Niloff
1 reference
H Goodman
1 reference
H Muntz
1 reference
M Muto
1 reference
1 August 1993
1 reference
1 reference
1583-1591
1 reference
Identifiers
1 reference
1 reference